Ján Kovaĺ
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
-
- Photodynamic Therapy Research Studies
Papers in
-
- Cancer therapeutics and mechanisms 10
- DNA and Nucleic Acid Chemistry 3
-
- Photodynamic Therapy Research Studies 8
- Co-authors
- Peter Fedoročko (23 shared papers)Jaromír Mikeš (19 shared papers)Rastislav Jendželovský (15 shared papers)Martin Kello (4 shared papers)Mária Kožurková (6 shared papers)Alois Kozubı́k (4 shared papers)Peter Solár (6 shared papers)Jana Plšíková (6 shared papers)
- Journals
- Molecular Cancer Therapeutics (2 papers)Photodiagnosis and Photodynamic Therapy (2 papers)Bioorganic Chemistry (2 papers)Toxicology in Vitro (2 papers)Photochemistry and Photobiology (2 papers)
- Partner nations
- SlovakiaCzechiaUnited States
In The Last Decade
Ján Kovaĺ
29 papers receiving 595 citations
Peers
Comparison fields: 5 of 83
- Toxicology 73
- Pulmonary and Respiratory Medicine 193
- Organic Chemistry 143
- Molecular Biology 325
- Oncology 116
Countries citing papers authored by Ján Kovaĺ
This map shows the geographic impact of Ján Kovaĺ's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ján Kovaĺ with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ján Kovaĺ more than expected).
Fields of papers citing papers by Ján Kovaĺ
This network shows the impact of papers produced by Ján Kovaĺ. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ján Kovaĺ. The network helps show where Ján Kovaĺ may publish in the future.
Co-authors
The 25 scholars most cited alongside Ján Kovaĺ, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 64 | |
| 2 | 2008 | 61 | |
| 3 | 2012 | 42 | |
| 4 | 2015 | 39 | |
| 5 | 2014 | 32 | |
| 6 | 2009 | 31 | |
| 7 | 2017 | 28 | |
| 8 | 2007 | 27 | |
| 9 | 2010 | 26 | |
| 10 | 2000 | 26 | |
| 11 | 2015 | 25 | |
| 12 | Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin. | 2007 | 19 |
| 13 | 2008 | 19 | |
| 14 | 2009 | 18 | |
| 15 | 2013 | 17 | |
| 16 | 2014 | 17 | |
| 17 | 2011 | 17 | |
| 18 | 2010 | 16 | |
| 19 | 2019 | 16 | |
| 20 | 2015 | 15 |
About Ján Kovaĺ
Ján Kovaĺ is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Biomedical Engineering and Organic Chemistry, having authored 29 papers that have together received 602 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (10 papers), Photodynamic Therapy Research Studies (8 papers), Nanoplatforms for cancer theranostics (5 papers), Bioactive Compounds and Antitumor Agents (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Synthesis and Biological Evaluation (3 papers) and DNA and Nucleic Acid Chemistry (3 papers). The work is most often cited by research in Toxicology (73 citations), Pulmonary and Respiratory Medicine (193 citations), Organic Chemistry (143 citations), Molecular Biology (325 citations) and Oncology (116 citations). Ján Kovaĺ has collaborated with scholars based in Slovakia, Czechia and United States. Frequent co-authors include Peter Fedoročko, Jaromír Mikeš, Rastislav Jendželovský, Martin Kello, Mária Kožurková, Alois Kozubı́k, Peter Solár, Jana Plšíková, Ladislav Janovec and Ján Imrich. Their work appears in journals such as Molecular Cancer Therapeutics, Photodiagnosis and Photodynamic Therapy, Bioorganic Chemistry, Toxicology in Vitro and Photochemistry and Photobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.